Matthew Kaplan

Insider Reports History

Location
Fort Lee, NJ
Signature
/s/ Matthew Kaplan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Kaplan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nuvectis Pharma, Inc. Director Common Stock 124,760 $728,598 $5.84 05 Nov 2025 Direct

Insider Reports Filed by Matthew Kaplan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NVCT Nuvectis Pharma, Inc. 05 Nov 2025 1 +$64,240 4 Director 06 Nov 2025, 08:00
NVCT Nuvectis Pharma, Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 16:31
NVCT Nuvectis Pharma, Inc. 13 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:22
NVCT Nuvectis Pharma, Inc. 16 Jun 2023 1 $0 4 Director 20 Jun 2023, 08:16
NVCT Nuvectis Pharma, Inc. 12 May 2022 2 +$50,633 4 Director 16 May 2022, 08:32
NVCT Nuvectis Pharma, Inc. 01 Apr 2022 1 $0 4 Director 05 Apr 2022, 16:48
NVCT Nuvectis Pharma, Inc. 08 Feb 2022 0 $0 3 Director 08 Feb 2022, 07:32